279 related articles for article (PubMed ID: 30348676)
1. Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with
Radomska KJ; Coulpier F; Gresset A; Schmitt A; Debbiche A; Lemoine S; Wolkenstein P; Vallat JM; Charnay P; Topilko P
Cancer Discov; 2019 Jan; 9(1):130-147. PubMed ID: 30348676
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal Loss of
Chen Z; Mo J; Brosseau JP; Shipman T; Wang Y; Liao CP; Cooper JM; Allaway RJ; Gosline SJC; Guinney J; Carroll TJ; Le LQ
Cancer Discov; 2019 Jan; 9(1):114-129. PubMed ID: 30348677
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
[TBL] [Abstract][Full Text] [Related]
4. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1
Pennanen P; Peltonen S; Kallionpää RA; Peltonen J
Mol Cell Biochem; 2018 Jul; 444(1-2):27-33. PubMed ID: 29185159
[TBL] [Abstract][Full Text] [Related]
5. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
Wu M; Wallace MR; Muir D
J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
[TBL] [Abstract][Full Text] [Related]
7. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
8. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
Mo J; Anastasaki C; Chen Z; Shipman T; Papke J; Yin K; Gutmann DH; Le LQ
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108355
[TBL] [Abstract][Full Text] [Related]
9. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
[TBL] [Abstract][Full Text] [Related]
10. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
[TBL] [Abstract][Full Text] [Related]
11. Econazole selectively induces cell death in NF1-homozygous mutant tumor cells.
Lakes YB; Moye SL; Mo J; Tegtmeyer M; Nehme R; Charlton M; Salinas G; McKay RM; Eggan K; Le LQ
Cell Rep Med; 2023 Dec; 4(12):101309. PubMed ID: 38086379
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous neurofibromas in the genomics era: current understanding and open questions.
Allaway RJ; Gosline SJC; La Rosa S; Knight P; Bakker A; Guinney J; Le LQ
Br J Cancer; 2018 Jun; 118(12):1539-1548. PubMed ID: 29695767
[TBL] [Abstract][Full Text] [Related]
13. Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice.
Coulpier F; Pulh P; Oubrou L; Naudet J; Fertitta L; Gregoire JM; Bocquet A; Schmitt AM; Wolkenstein P; Radomska KJ; Topilko P
Transl Res; 2023 Nov; 261():16-27. PubMed ID: 37331503
[TBL] [Abstract][Full Text] [Related]
14. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
Jiang C; McKay RM; Lee SY; Romo CG; Blakeley JO; Haniffa M; Serra E; Steensma MR; Largaespada D; Le LQ
J Invest Dermatol; 2023 Aug; 143(8):1369-1377. PubMed ID: 37318402
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
[TBL] [Abstract][Full Text] [Related]
17. Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas.
Karaosmanoglu B; Kocaefe ÇY; Söylemezoğlu F; Anlar B; Varan A; Vargel İ; Ayter S
Childs Nerv Syst; 2018 May; 34(5):877-882. PubMed ID: 29455242
[TBL] [Abstract][Full Text] [Related]
18. Injury signals cooperate with Nf1 loss to relieve the tumor-suppressive environment of adult peripheral nerve.
Ribeiro S; Napoli I; White IJ; Parrinello S; Flanagan AM; Suter U; Parada LF; Lloyd AC
Cell Rep; 2013 Oct; 5(1):126-36. PubMed ID: 24075988
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
20. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
Patritti Cram J; Wu J; Coover RA; Rizvi TA; Chaney KE; Ravindran R; Cancelas JA; Spinner RJ; Ratner N
Elife; 2022 Mar; 11():. PubMed ID: 35311647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]